{"id":"https://openalex.org/W2154228420","doi":"https://doi.org/10.1016/s2215-0366(15)00004-8","title":"Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people","display_name":"Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people","alternate_titles":[],"publication_year":2015,"publication_date":"2015-03-31","ids":{"openalex":"https://openalex.org/W2154228420","doi":"https://doi.org/10.1016/s2215-0366(15)00004-8","mag":"2154228420","pmid":"https://pubmed.ncbi.nlm.nih.gov/26360089"},"language":"en","primary_location":{"id":"doi:10.1016/s2215-0366(15)00004-8","doi":"https://doi.org/10.1016/s2215-0366(15)00004-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2215-0366(15)00004-8","pdf_url":null,"source":{"id":"https://openalex.org/S2531556786","display_name":"The Lancet Psychiatry","issn_l":"2215-0366","issn":["2215-0366","2215-0374"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2154228420"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Pharmacological_cognitive_enhancement_treatment_of_neuropsychiatric_disorders_and_lifestyle_use_by_healthy_people/23776383","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030827457","display_name":"Barbara Jacquelyn Sahakian","orcid":"https://orcid.org/0000-0001-7352-1745","observed_orcids":["https://orcid.org/0000-0001-7352-1745","https://orcid.org/0000-0002-0521-5735"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Barbara J Sahakian","raw_affiliation_strings":["Department of Psychiatry, Cambridge, UK. Electronic address: bjs1001@medschl.cam.ac.uk","Department of Psychiatry, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Cambridge, UK. Electronic address: bjs1001@medschl.cam.ac.uk","institution_ids":["https://openalex.org/I241749"]},{"raw_affiliation_string":"Department of Psychiatry, Cambridge, UK","institution_ids":["https://openalex.org/I241749"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064203623","display_name":"Sharon Morein\u2010Zamir","orcid":"https://orcid.org/0000-0002-6919-6692","observed_orcids":["https://orcid.org/0000-0002-6919-6692"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]},{"id":"https://openalex.org/I87048295","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I87048295"]},{"id":"https://openalex.org/I90344618","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210087105","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sharon Morein-Zamir","raw_affiliation_strings":["Medical Research Council-Wellcome Trust Behavioural and Clinical Neuroscience Institute, Addenbrooke's Hospital, Cambridge, UK; Department of Psychology, University of Cambridge, Cambridge, UK","Department of Psychology, University of Cambridge, Cambridge, UK; Medical Research Council\u2013Wellcome Trust Behavioural and Clinical Neuroscience Institute, Addenbrooke's Hospital, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Council-Wellcome Trust Behavioural and Clinical Neuroscience Institute, Addenbrooke's Hospital, Cambridge, UK; Department of Psychology, University of Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210156194","https://openalex.org/I87048295","https://openalex.org/I90344618"]},{"raw_affiliation_string":"Department of Psychology, University of Cambridge, Cambridge, UK; Medical Research Council\u2013Wellcome Trust Behavioural and Clinical Neuroscience Institute, Addenbrooke's Hospital, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210156194","https://openalex.org/I87048295","https://openalex.org/I90344618"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5030827457"],"corresponding_institution_ids":["https://openalex.org/I241749"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":null,"fwci":34.9259,"has_fulltext":false,"cited_by_count":61,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99691981,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"2","issue":"4","first_page":"357","last_page":"362"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11953","display_name":"Neuroethics, Human Enhancement, Biomedical Innovations","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11953","display_name":"Neuroethics, Human Enhancement, Biomedical Innovations","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacological-cognitive-enhancement","display_name":"pharmacological cognitive enhancement","score":0.953000009059906},{"id":"https://openalex.org/keywords/neuropsychiatric-disorders","display_name":"neuropsychiatric disorders","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.6330000162124634},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.8809999823570251},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.9919999837875366},{"id":"https://openalex.org/keywords/modafinil","display_name":"modafinil","score":1.0},{"id":"https://openalex.org/keywords/nootropics","display_name":"nootropic drugs","score":0.9240000247955322},{"id":"https://openalex.org/keywords/healthy-people","display_name":"healthy people","score":0.4390000104904175},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.7609999775886536},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/prefrontal-cortex","display_name":"prefrontal cortex","score":0.7059999704360962},{"id":"https://openalex.org/keywords/cognitive-control","display_name":"cognitive control","score":0.8050000071525574},{"id":"https://openalex.org/keywords/ethics-of-cognitive-enhancement","display_name":"ethics of cognitive enhancement","score":0.7570000290870667},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8230000138282776}],"concepts":[{"id":"https://openalex.org/C2780714222","wikidata":"https://www.wikidata.org/wiki/Q410441","display_name":"Modafinil","level":2,"score":0.7709294557571411},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.7311793565750122},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.6357071399688721},{"id":"https://openalex.org/C27502469","wikidata":"https://www.wikidata.org/wiki/Q906343","display_name":"Dysfunctional family","level":2,"score":0.5806096196174622},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.554640531539917},{"id":"https://openalex.org/C139265228","wikidata":"https://www.wikidata.org/wiki/Q5283089","display_name":"Distress","level":2,"score":0.48831793665885925},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4457542896270752},{"id":"https://openalex.org/C2779056891","wikidata":"https://www.wikidata.org/wiki/Q412690","display_name":"Galantamine","level":5,"score":0.412314772605896},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40880286693573},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.3958045244216919},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3786477744579315},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.33143138885498047},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.3136574625968933},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.30877289175987244},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077408","descriptor_name":"Modafinil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008019","descriptor_name":"Life Style","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/s2215-0366(15)00004-8","doi":"https://doi.org/10.1016/s2215-0366(15)00004-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2215-0366(15)00004-8","pdf_url":null,"source":{"id":"https://openalex.org/S2531556786","display_name":"The Lancet Psychiatry","issn_l":"2215-0366","issn":["2215-0366","2215-0374"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Psychiatry","raw_type":"journal-article"},{"id":"pmid:26360089","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26360089","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The lancet. Psychiatry","raw_type":"Journal Article"},{"id":"pmh:oai:arro.anglia.ac.uk:701924","doi":null,"is_oa":false,"landing_page_url":"https://arro.anglia.ac.uk/id/eprint/701924/","pdf_url":null,"source":{"id":"https://openalex.org/S4306402145","display_name":"Anglia Ruskin Research Online (Anglia Ruskin University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I51216347","host_organization_name":"Anglia Ruskin University","host_organization_lineage":["https://openalex.org/I51216347"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/23776383","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Pharmacological_cognitive_enhancement_treatment_of_neuropsychiatric_disorders_and_lifestyle_use_by_healthy_people/23776383","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/23776383","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Pharmacological_cognitive_enhancement_treatment_of_neuropsychiatric_disorders_and_lifestyle_use_by_healthy_people/23776383","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5247087841","display_name":"The neural and neurochemical basis of compulsivity in humans and other animals.","funder_award_id":"089589/Z/09/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G722994910","display_name":null,"funder_award_id":"G00001354","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G8875240975","display_name":"Behavioural and Clinical Neuroscience Institute (BCNI)","funder_award_id":"093875/Z/10/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":68,"referenced_works":["https://openalex.org/W146015845","https://openalex.org/W359481183","https://openalex.org/W1535268439","https://openalex.org/W1696280731","https://openalex.org/W1760119900","https://openalex.org/W1966136869","https://openalex.org/W1970031540","https://openalex.org/W1970977913","https://openalex.org/W1972490292","https://openalex.org/W1973676219","https://openalex.org/W1974134079","https://openalex.org/W1981307852","https://openalex.org/W1984024293","https://openalex.org/W1985339809","https://openalex.org/W1992749381","https://openalex.org/W1996288934","https://openalex.org/W1997695932","https://openalex.org/W1999255620","https://openalex.org/W1999876220","https://openalex.org/W2000407516","https://openalex.org/W2014159374","https://openalex.org/W2020406157","https://openalex.org/W2020924268","https://openalex.org/W2025412287","https://openalex.org/W2025431637","https://openalex.org/W2027838133","https://openalex.org/W2030677166","https://openalex.org/W2032982103","https://openalex.org/W2037163186","https://openalex.org/W2047600379","https://openalex.org/W2062274644","https://openalex.org/W2066353027","https://openalex.org/W2067756660","https://openalex.org/W2071411087","https://openalex.org/W2074111622","https://openalex.org/W2087080589","https://openalex.org/W2087969332","https://openalex.org/W2087980352","https://openalex.org/W2088801032","https://openalex.org/W2094055797","https://openalex.org/W2094906445","https://openalex.org/W2099564435","https://openalex.org/W2104068787","https://openalex.org/W2104425663","https://openalex.org/W2107644167","https://openalex.org/W2118189290","https://openalex.org/W2119815552","https://openalex.org/W2121684756","https://openalex.org/W2124785336","https://openalex.org/W2130987666","https://openalex.org/W2132248371","https://openalex.org/W2132444666","https://openalex.org/W2138482980","https://openalex.org/W2139700465","https://openalex.org/W2147138162","https://openalex.org/W2151585937","https://openalex.org/W2151633901","https://openalex.org/W2156161224","https://openalex.org/W2156900283","https://openalex.org/W2159630298","https://openalex.org/W2163050774","https://openalex.org/W2164544300","https://openalex.org/W2168569741","https://openalex.org/W4205344678","https://openalex.org/W4206327837","https://openalex.org/W4238215801","https://openalex.org/W4245191789","https://openalex.org/W4323966329"],"related_works":["https://openalex.org/W2106342190","https://openalex.org/W2513312757","https://openalex.org/W2606538010","https://openalex.org/W4241142247","https://openalex.org/W2148085544","https://openalex.org/W4320723597","https://openalex.org/W1598393016","https://openalex.org/W2416015232","https://openalex.org/W2906675106"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2154228420","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
